Cost-effectiveness analysis of a screening program for breast cancer in Vietnam

Value in Health Regional Issues

Volumn 2, Issue 1, 2013, Pages 21-28

  Nguyen, Lan Hoang ^a,b   Laohasiriwong, Wongsa ^a   Stewart, John Frederick ^c   Wright, Pamela ^d   Nguyen, Yen Thi Bach ^e   Coyte, Peter C ^f  

^a KHON KAEN UNIVERSITY   (Thailand)

^b HUE UNIVERSITY   (Viet Nam)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Medical Committee Netherlands Vietnam   (Netherlands)

^e HANOI MEDICAL UNIVERSITY   (Viet Nam)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Clinical breast examination; Cost effectiveness; Screening program; Vietnam

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BREAST CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ETHNIC GROUP; FEMALE; HEALTH CARE POLICY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIET NAM; VIETNAMESE; WORLD HEALTH ORGANIZATION;

EID: 84877127095     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2013.02.004     Document Type: Article

References (45)

1. World Cancer Report 2008. Lyon Cedex, France 2008, The International Agency for Research on Cancer. B. Peter, L. Bernard (Eds.).
2. Globocal 2008: country fast stat. Available from: . [Accessed June 20, 2012]. http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900.
3. Anderson B.O., Yip C.H., Smith R.A., et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008, 113:2221-2243.
4. Bray F., McCarron P., Parkin D.M. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004, 6:229-239.
5. Leong S.P., Shen Z.Z., Liu T.J., et al. Is breast cancer the same disease in Asian and Western countries?. World J Surg 2010, 34:2308-2324.
6. Okonkwo Q.L., Draisma G., der Kinderen A., et al. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008, 100:1290-1300.
7. Sarvazyan A., Egorov V., Son J.S., et al. Cost-effectiveness screening for breast cancer worldwide: current state and future directions. Breast Cancer (Auckl) 2008, 1:91-99.
8. Park B.W., Kim S.I., Kim M.H., et al. Clinical breast examination for screening of asymptomatic women: the importance of clinical breast examination for breast cancer detection. Yonsei Med J 2000, 41:312-318.
9. Laxminarayan R, Chow J, Shahid-Salles SA. Intervention cost-effectiveness: Overview of main message. In: Jamison DT, Breman JD, Measham AR, et al., editors. Disease Control Priorities in Developing Countries. Vol. 2nd. Oxford University Press. Washington, DC, 2006.
10. Miller A.B. Practical applications for clinical breast examination (CBE) and breast self-examination (BSE) in screening and early detection of breast cancer. Breast Care (Basel) 2008, 3:17-20.
11. World Bank. World Development Indicators database. GDP per capita. Available from: . [Accessed March 9, 2012]. http://data.worldbank.org/indicator/NY.GDP.PCAP.CP.
12. Duc N.B., et al. Epidemiology and program of control and prevention for cancer: preliminary report of National Cancer Project period 2008-2010 [in Vietnamese]. Vietnamese J Oncol 2010, 2:21-31.
13. Anh P.T., Duc N.B. The situation with cancer control in Vietnam. Jpn J Clin Oncol 2002, 32(Suppl):S92-S97.
14. Ngoan le T., Lua N.T., Hang L.T. Cancer mortality pattern in Viet Nam. Asian Pac J Cancer 2007, Prev8:535-538.
15. Pfizer Facts. The burden of cancer in Asia. 2008. Available from: . [Accessed March 19, 2012]. http://www.pfizer.com/files/products/cancers%20in_asia.pdf.
16. Vietnamese Government. National Cancer Control Project, Period of 2008-2010 [in Vietnamese]. Ministry of Health. Hanoi, 2007.
17. Dung N., et al. Report of result of screening for breast cancer in two districts of ThuaThien Hue in 2008 [in Vietnamese]. Vietnamese J Oncol 2009, 1:20-28.
18. Trung N.T., et al. Results of screening program for breast cancer and cervix cancer at 4822 women aged 40-54 in Thai Nguyen province in 2008 [in Vietnamese]. Vietnamese J Oncol 2009, 1:29-33.
19. Khoa T.D., et al. Screening for breast cancer at 9651 women in Hanoi in 2008 [in Vietnamese]. Vietnamese J Oncol 2009, 1:12-17.
20. Hoa N.L., et al. Results of detecting early breast cancer at HaiPhong's women in 2008 [in Vietnamese]. Vietnamese J Oncol 2009, 1:18-19.
21. Briggs A., Sculpher M., Claxton K. Decision Modeling for Health Economic Evaluation 2006, Oxford University Press, New York.
22. World Health Organization. Life table for Vietnam. 2010. Available from: . [Accessed January 15, 2010]. http://apps.who.int/whois/database/life_tables/.
23. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003, World Health Organization, Geneva. T. Tan-Torres, R. Baltussen, T. Adam (Eds.).
24. Duc Nguyen Ba, et al. Breast cancer situation in women in some provinces/cities from 2001 to 2007 [in Vietnamese]. Vietnamese J Oncol 2009, 1:5-11.
25. Documentation: Report of screening program for Cervical and Breast Cancer, Period 2008-2010 [in Vietnamese]. National Oncological Institutes. Hanoi, 2011.
26. Lan NH, Wongsa L, Steward JF. Survival time and risk factors for breast cancer patients in Vietnam. Glob Health Action 2013;6:18860.
27. Szabo L. Breast cancer: risk of relapse low after surviving 5 years. USA Today. Updated August 13, 2008. Available from: . [Accessed April 24, 2012]. http://www.usatoday.com/news/health/2008-08-12-breast-cancer-relapse_N.htm.
28. Public law: Joint Circular of Ministry of Finance and Ministry of Health on guideline of management and the use of budget for National Health Program in 2006-2010. Pub. L. No. 147/2007/TTLT-BYT-BTC (December 12, 2007) [in Vietnamese]. Available from: . [Accessed January 26, 2012]. http://vanban.cafeluat.com/van-ban/thong-tu-lien-tich/36296-thong-tu-lien-tich-147.
29. Okubo I., Glick H., Frumkin H., et al. Cost-effectiveness analysis of mass screening for breast cancer in Japan. Cancer 1991, 67:2021-2029.
30. Oestreicher N., Lehman C.D., Seger D.J., et al. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR 2005, 184:428-432.
31. Documentation: List of Hospital Charge for Medical Tests. Hue Central Hospital. Hue City, 2008.
32. Lan NH, Wongsa L, Steward JF, et al. Cost of treatment for breast cancer in central Vietnam. Glob Health Action 2013; 6:18872.
33. Vietnamese General Statistics Office. Statistics of consumer price index by year. Available from: . [Accessed September 20, 2011]. http://www.gso.gv.vn.
34. Ministry of Finance. Rate of Exchange in July 2008. Available from: . [Accessed February 20, 2012]. http://www.mof.gov.vn/portal/page/portal/mof_vn/1641775.
35. Barendregt J.J. Ersatz User Guide Version 1.1 2009-2010, EpiGear International Pty Ltd, Kelvin Grove, Australia.
36. Ohnuki K., Kuriyama S., Shoji N., et al. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years. Cancer Sci 2006, 97:1242-1247.
37. Devi B.C., Tang T.S., Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007, 18:1172-1176.
38. Lam H.S. Update in breast cancer screening. Review article. JHK Coll Radiol 2004, 7:171-180.
39. Pisani P., Parkin D.M., Ngelangel C., et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006, 118:149-154.
40. Anderson B.O., Braun S., Lim S., et al. Early detection of breast cancer in countries with limited resources. Breast J 2003, 9(Suppl. 2):S51-S59.
41. WHO-CHOICE. Cost-effectiveness thresholds. Available from: . [Accessed March 16, 2012]. http://www.who.int/choice/costs/CER_thresholds/en/index.html.
42. Epidemiology 2004, Leon Gordis, Elsevier Saunders. Philadelphia, Pennsylvania, USA. 3rd ed.
43. WHO Representative Office in Vietnam. Health financing. Available from: . [Accessed June 11, 2012]. http://www2.wpro.who.int/vietnam/sites/dhs/health_financing/.
44. Albert U.S., Schulz K.D. Clinical breast examination: what can be recommended for its use to detect breast cancer in countries with limited resources?. Breast J 2003, 9(Suppl. 2):S90-S93.
45. Asadzadeh V.F., Broeders M.J., Kiemeney L.A., et al. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran. Asian Pac J Cancer Prev 2011, 12:2467-2475.